Literature DB >> 24134724

Evaluation of clinical and laboratory correlates of sickle leg ulcers.

Anazoeze Jude Madu1, Agozie Ubesie, Kenechi Anthony Madu, Bismarck Okwor, Chukwudi Anigbo.   

Abstract

The exact mechanism for the occurrence of sickle leg ulcers (SLUs) has not been fully explained, although, popular opinion supports a multifactorial etio-pathogenetic process. Leg ulceration in sickle cell is a chronic and debilitating condition which is difficult to treat and may worsen the psychosocial impact of this illness. This study aims to evaluate the laboratory and clinical correlates of SLUs. One hundred sixty-seven patients who had been diagnosed with sickle cell anemia (homozygous S) had their steady-state hemoglobin concentration (Hb), hematocrit, white cell count, platelet count, serum bilirubin, and aspartate transaminase (AST) as well as frequency of crisis per annum evaluated with respect to their relationship to the occurrence of leg ulcers. They were aged 6-53 years (mean age 24.3 years), and prevalence of leg ulcer was found to be 2.75 per 1000 (2.54 per 1000 in females and 2.83 per 1000 in males). The independent sample t-test showed a significant difference in the serum AST levels in those with SLU (p = 0.029), though a positive correlation did not exist. Other predictors of disease severity found to have positive relationship with each other were the AST and total serum bilirubin 0.207 (p = 0.012); Hb and age 0.130 (p = 0.035); Hb and white cell count -0.159 (p = 0.010), white cell count and age -0.113 (p = 0.018). SLUs do not occur in patients with severe disease in sickle cell. The clinical and laboratory indicators of severe sickle cell disease do not correlate positively with the occurrence of SLU. Serum AST may have a relationship with leg ulceration in these patients. Environmental factors most likely play a major part in the etiopathogenesis of leg ulcer and this may require further studies in different sociocultural settings.
© 2013 by the Wound Healing Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24134724     DOI: 10.1111/wrr.12100

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  5 in total

1.  Prevalence and Predictive Factors for Leg Ulcers in Sickle Cell Disease Patients in Saudi Arabia: A Cross-Sectional Observational Study.

Authors:  Feroze Kaliyadan; Ahmed Z Alkhars; Alreem A Albaqshi; Hajar M AlHajri; Norah K Albaqshi; Rawan M Aldihnayn; Zainab Y Almarzooq
Journal:  Cureus       Date:  2020-10-31

2.  Biochemical aspects of effects of mesenchymal stem cell treatment in chronic wounds progressive healing.

Authors:  Anjali Athanerey; Neha Rani Verma; Piyush Bhargava; Dnyanesh Amle; P K Patra; Awanish Kumar
Journal:  Cell Tissue Bank       Date:  2022-07-18       Impact factor: 1.752

3.  Intima-media thickness of the common femoral artery as a marker of leg ulceration in sickle cell disease patients.

Authors:  Oluwagbemiga O Ayoola; Rahman A Bolarinwa; Uvie U Onakpoya; Tewogbade A Adedeji; Chidiogo C Onwuka; Bukunmi M Idowu
Journal:  Blood Adv       Date:  2018-11-27

Review 4.  Morphine for the treatment of pain in sickle cell disease.

Authors:  Mihir Gupta; Lilian Msambichaka; Samir K Ballas; Kalpna Gupta
Journal:  ScientificWorldJournal       Date:  2015-01-12

5.  Prevalence of people with sickle cell disease and leg ulcers in Brazil: Socioeconomic and clinical overview.

Authors:  Josimare Aparecida Otoni Spira; Eline Lima Borges; Antônio Carlos Martins Guedes; Paula Gabriela Ribeiro Andrade; Vera Lúcia de Araújo Nogueira Lima
Journal:  PLoS One       Date:  2022-09-09       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.